Early outcome of a phase I study of interrupted pulse dosed axitinib combined with FOLFOX or FOLFIRI in refractory metastatic colorectal cancer.
Eric Roeland
No relevant relationships to disclose
Kelly Anne Shimabukuro
No relevant relationships to disclose
Paul Timothy Fanta
No relevant relationships to disclose
Bethany H. Parker
No relevant relationships to disclose
Michael Hwang
No relevant relationships to disclose
Tony R. Reid
No relevant relationships to disclose